Show simple item record

dc.contributor.authorJiménez, Rosario
dc.contributor.authorToral Jiménez, Marta
dc.contributor.authorGómez Guzmán, Manuel 
dc.contributor.authorRomero Pérez, Miguel 
dc.contributor.authorSánchez, Manuel
dc.contributor.authorMahmoud, Ayman M.
dc.contributor.authorDuarte, Juan
dc.date.accessioned2019-07-05T08:00:27Z
dc.date.available2019-07-05T08:00:27Z
dc.date.issued2018-07-25
dc.identifier.other30046379
dc.identifier.urihttp://hdl.handle.net/10481/56303
dc.description.abstractHyperglycemia induces oxidative stress and plays a substantial role in the progression of vascular diseases. Here, we demonstrated the potentiality of peroxisome proliferator-activated receptor (PPAR)β/δ activation in attenuating high glucose-induced oxidative stress in endothelial cells and diabetic rats, pointing to the involvement of nuclear factor erythroid 2-related factor 2 (Nrf2). HUVECs exposed to high glucose showed increased levels of reactive oxygen species (ROS) and upregulated NOX-2, NOX-4, Nrf2, and NQO-1 effects that were significantly reversed by the PPARβ/δ agonists GW0742 and L165041. Both PPARβ/δ agonists, in a concentration-dependent manner, induced transcriptional and protein upregulation of heme oxygenase-1 (HO-1) under low- and high-glucose conditions. All effects of PPARβ/δ agonists were reversed by either pharmacological inhibition or siRNA-based downregulation of PPARβ/δ. These in vitro findings were confirmed in diabetic rats treated with GW0742. In conclusion, PPARβ/δ activation confers vascular protection against hyperglycemia-induced oxidative stress by suppressing NOX-2 and NOX-4 expression plus a direct induction of HO-1; with the subsequent downregulation of the Nrf2 pathway. Thus, PPARβ/δ activation could be of interest to prevent the progression of diabetic vascular complications.es_ES
dc.description.sponsorshipThis work was supported by Grants from Ministerio de Economía y Competitividad and Fondo Europeo de Desar- rollo Regional (FEDER) (SAF2010-22066-C02-01, SAF2010-22066-C02-02, SAF2011-28150, SAF2014-55523- R), Junta de Andalucía (Proyecto de excelencia, P12-CTS- 2722), and Instituto de Salud Carlos III (RIC RD12/0042/ 0011), Spain.es_ES
dc.language.isoenges_ES
dc.publisherHindawies_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectNrf2es_ES
dc.subjectPPARes_ES
dc.subjectHyperglycemiaes_ES
dc.subjectDiabetes es_ES
dc.subjectOxidative Stresses_ES
dc.subjectHUVECses_ES
dc.titleThe Role of Nrf2 Signaling in PPARβ/δ-Mediated Vascular Protection against Hyperglycemia-Induced Oxidative Stresses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1155/2018/5852706


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España